USFDA pulls up Granules India for lapses in maintaining storage facilities, equipment at Telangana plant

The USFDA has issued a warning to Granules India for contamination and improper equipment maintenance at its Telangana facility. Inspectors found significant contamination, bird droppings, and torn CGMP records during their visit. The agency demands prompt corrective actions from the company to rectify these violations, emphasizing the need for effective oversight and improved quality systems.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qMbUN2y
via IFTTT